Dysregulation of a number of pathways has been hypothesized to mechanistically link obesity with increased risk of breast cancer recurrence in humans, including changes in circulating adipokines, insulin/IGF-1, sex hormones, and chronic inflammation [29, 84–86]. The gene discussed is INS; the disease is breast carcinoma.